This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ZERO's CEO Steps Down After Thirteen Years Of Leadership

Skip was a driving force in the movement to bring prostate cancer awareness from a backwater activity to a significant and viable activity to find a cure. Working with celebrities from Rudy Giuliani to Julius "Dr. J." Erving, and organizations including Major League Baseball, National Hockey League and NASCAR, Skip worked to educate men about their health and the importance of early detection.

When Skip became CEO, the organization changed its name from National Prostate Cancer Coalition to ZERO – The Project to End Prostate Cancer. The organization has grown from a staff of six to sixteen and recently updated its name to ZERO – The End of Prostate Cancer during a rebranding. Skip worked to bring the organization to full transparency, attaining 501c3 charity and Better Business Bureau certifications.

"Skip is a pioneer in the field of men's health," said Jamie Bearse, incoming CEO at ZERO. "He does not believe in complacency and his energy and unique approach to challenges propelled ZERO to the front lines in the fight to end prostate cancer. His passion will be greatly missed as we continue to work to end this disease."

Skip, his wife Julie and son Harry are moving to upstate New York where Skip will join his father-in-law in running his family's industrial piping business.

About ZERO — The End of Prostate Cancer ( Zero prostate cancer deaths. Zero prostate cancer cases and for those with prostate cancer, it means a zero PSA. Our name conveys what we stand for – all action and zero tolerance for prostate cancer.

As ZERO — The End of Prostate Cancer, we commit ourselves not only to reduce prostate cancer or alleviate the pain from the disease but to end it. We see a future where all men who have been diagnosed with prostate cancer will be cured or manage their illness with good quality of life, with the support they need to minimize physical and emotional suffering and to cope effectively throughout their cancer journeys.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community


Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs